Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Scott Requadt currently holds 50,000 shares of ESSA Pharma Inc. (EPIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Requadt has been a net buyer of EPIX stock. They have purchased $239.4K and sold $0 worth of shares.
Scott Requadt's most recent insider trade was on Oct 9, 2025, when they sold 30,002 shares at $0.00 per share.
Scott Requadt serves as Executive at ESSA Pharma Inc. (EPIX). They have executed 16 insider transactions totaling $239.4K over their tenure at the company.
Scott Requadt holds the position of Executive at ESSA Pharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Scott Requadt has shown a buying trading pattern, with $239.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Scott Requadt was on Jul 29, 2022, when they purchased $167.4K worth of TALS shares. This transaction involved 39,382 shares at $4.25 per share.
Scott Requadt currently owns 50,000 shares of ESSA Pharma Inc. (EPIX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Scott Requadt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Scott Requadt has 16 Form 4 filings on record as an insider at ESSA Pharma Inc..
Set alerts for Scott Requadt and 40,000+ other insiders.